Cinthia V. Pastuskovas

Statistics

Publications

Citations

736

H-Index

Active since

1995

Affiliations

Acentech (United States)(Current)

Instituto de Investigación Médica Mercedes y Martín Ferreyra

Cinthia V. Pastuskovas is an author at Acentech (United States) specializing in pharmacology, pharmacokinetics of monoclonal antibodies, and pharmacy.

Publications per year

1995–2023

Publications

Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor

Rong Deng, Daniela Bumbaca, Cinthia V. Pastuskovas et al. · mAbs · 2016 · 201 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism

Ben‐Quan Shen, Daniela Bumbaca, Ola M. Saad et al. · Current Drug Metabolism · 2012 · 137 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model

Cinthia V. Pastuskovas, Eduardo E. Mundo, Simon P. Williams et al. · Molecular Cancer Therapeutics · 2012 · 102 citations

Pharmacy, Oncology, Pharmacology +17

Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics

Kapil Gadkar, Cinthia V. Pastuskovas, Jennifer E. Le Couter et al. · Investigative Ophthalmology & Visual Science · 2015 · 68 citations

Pharmacy, Ophthalmology, Pharmacology +17

Characterization of Therapeutic Monoclonal Antibodies Reveals Differences Between In Vitro and In Vivo Time-Course Studies

Sheng Yin, Cinthia V. Pastuskovas, Leslie A. Khawli et al. · Pharmaceutical Research · 2012 · 60 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

1–5 of 11